Fostamatinib for the treatment of immune thrombocytopenia in adults
Author:
Affiliation:
1. Department of Pharmacy, Atrium Health, Levine Cancer Institute, Charlotte, NC
2. Department of Hematology/Oncology, Atrium Health, Levine Cancer Institute, Rock Hill, SC
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/76/11/789/28665457/zxz052.pdf
Reference28 articles.
1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood.,2009
2. Clinical updates in adult immune thrombocytopenia;Lambert;Blood.,2017
3. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease;Zeller;Acta Paediatr.,2005
4. The incidence of idiopathic thrombocytopenic purpura in adults increases with age;Frederiksen;Blood.,1999
5. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review;Neunert;J Thromb Haemost.,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience;Blood Coagulation & Fibrinolysis;2024-07-16
2. Translating mechanisms into therapeutic strategies for immune thrombocytopenia (ITP): Lessons from clinical trials;Thrombosis Research;2024-03
3. Evaluating fostamatinib disodium as a treatment option for immune thrombocytopenia in adult patients;Expert Opinion on Pharmacotherapy;2022-05-24
4. Recent advances in treatments of adult immune thrombocytopenia;Blood Research;2022-04-30
5. In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma;International Journal of General Medicine;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3